Literature DB >> 25344870

Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection.

Zhaohui Zhang1, Fei Ma, Feng Zhou, Yibing Chen, Xiaoyan Wang, Hongxin Zhang, Yong Zhu, Jianwei Bi, Yiguan Zhang.   

Abstract

Previous studies have demonstrated that circadian negative feedback loop genes play an important role in the development and progression of many cancers. However, the associations between single-nucleotide polymorphisms (SNPs) in these genes and the clinical outcomes of hepatocellular carcinoma (HCC) after surgical resection have not been studied so far. Thirteen functional SNPs in circadian genes were genotyped using the Sequenom iPLEX genotyping system in a cohort of 489 Chinese HCC patients who received radical resection. Multivariate Cox proportional hazards model and Kaplan-Meier curve were used for the prognosis analysis. Cumulative effect analysis and survival tree analysis were used for the multiple SNPs analysis. Four individual SNPs, including rs3027178 in PER1, rs228669 and rs2640908 in PER3 and rs3809236 in CRY1, were significantly associated with overall survival (OS) of HCC patients, and three SNPs, including rs3027178 in PER1, rs228729 in PER3 and rs3809236 in CRY1, were significantly associated with recurrence-free survival (RFS). Moreover, we observed a cumulative effect of significant SNPs on OS and RFS (P for trend < 0.001 for both). Survival tree analysis indicated that wild genotype of rs228729 in PER3 was the primary risk factor contributing to HCC patients' RFS. Our study suggests that the polymorphisms in circadian negative feedback loop genes may serve as independent prognostic biomarkers in predicting clinical outcomes for HCC patients who received radical resection. Further studies with different ethnicities are needed to validate our findings and generalize its clinical utility.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25344870     DOI: 10.1007/s12032-014-0179-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  35 in total

Review 1.  Cancer pharmacogenetics: polymorphisms, pathways and beyond.

Authors:  Cornelia M Ulrich; Kim Robien; Howard L McLeod
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

Review 2.  Molecular signals of Mammalian circadian clock.

Authors:  Jing Zhang; Xin Dong; Yoshito Fujimoto; Hitoshi Okamura
Journal:  Kobe J Med Sci       Date:  2004

Review 3.  The role of mammalian circadian proteins in normal physiology and genotoxic stress responses.

Authors:  Roman V Kondratov; Victoria Y Gorbacheva; Marina P Antoch
Journal:  Curr Top Dev Biol       Date:  2007       Impact factor: 4.897

4.  A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.

Authors:  Jing Xu; Zhong-Yang Shen; Xin-Guo Chen; Qing Zhang; Hui-Jie Bian; Ping Zhu; Hui-Yun Xu; Fei Song; Xiang-Min Yang; Li Mi; Qing-Chuan Zhao; Rong Tian; Qiang Feng; Si-He Zhang; Yu Li; Jian-Li Jiang; Ling Li; Xiao-Ling Yu; Zheng Zhang; Zhi-Nan Chen
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

5.  Carcinogenicity of shift-work, painting, and fire-fighting.

Authors:  Kurt Straif; Robert Baan; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Véronique Bouvard; Andrea Altieri; Lamia Benbrahim-Tallaa; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2007-12       Impact factor: 41.316

Review 6.  Circadian clock control of the cellular response to DNA damage.

Authors:  Aziz Sancar; Laura A Lindsey-Boltz; Tae-Hong Kang; Joyce T Reardon; Jin Hyup Lee; Nuri Ozturk
Journal:  FEBS Lett       Date:  2010-03-15       Impact factor: 4.124

7.  Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer.

Authors:  Michele A Gauger; Aziz Sancar
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

8.  Circadian rhythm and its role in malignancy.

Authors:  Sobia Rana; Saqib Mahmood
Journal:  J Circadian Rhythms       Date:  2010-03-31

9.  Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.

Authors:  Yong Zhu; Richard G Stevens; Aaron E Hoffman; Liesel M Fitzgerald; Erika M Kwon; Elaine A Ostrander; Scott Davis; Tongzhang Zheng; Janet L Stanford
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

10.  Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk.

Authors:  Yong Zhu; Richard G Stevens; Derek Leaderer; Aaron Hoffman; Theodore Holford; Yawei Zhang; Heather N Brown; Tongzhang Zheng
Journal:  Breast Cancer Res Treat       Date:  2007-04-24       Impact factor: 4.872

View more
  10 in total

1.  Ahypoxia-related signature enhances the prediction of the prognosis in hepatocellular carcinoma patients and correlates with sorafenib treatment response.

Authors:  Hong-Ye Jiang; Gang Ning; Yen-Sheng Wang; Wei-Biao Lv
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

2.  Endotoxin Disrupts Circadian Rhythms in Macrophages via Reactive Oxygen Species.

Authors:  Yusi Wang; Paramita Pati; Yiming Xu; Feng Chen; David W Stepp; Yuqing Huo; R Daniel Rudic; David J R Fulton
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

3.  Genetic polymorphisms in circadian negative feedback regulation genes predict overall survival and response to chemotherapy in gastric cancer patients.

Authors:  Falin Qu; Qing Qiao; Nan Wang; Gang Ji; Huadong Zhao; Li He; Haichao Wang; Guoqiang Bao
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

4.  Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis.

Authors:  Clara Benna; Senthilkumar Rajendran; Giovanna Spiro; Saveria Tropea; Paolo Del Fiore; Carlo Riccardo Rossi; Simone Mocellin
Journal:  J Transl Med       Date:  2018-12-05       Impact factor: 5.531

5.  Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer.

Authors:  Yibing Chen; Dandan Wang; Yucen Song; Xiaofei Zhang; Zhihui Jiao; Juqin Dong; Lin Lü; Zhengzhi Zou; Wei Du; Falin Qu
Journal:  Cancer Med       Date:  2019-03-07       Impact factor: 4.452

6.  Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility.

Authors:  Monika Lesicka; Ewa Jabłońska; Edyta Wieczorek; Beata Pepłońska; Jolanta Gromadzińska; Barbara Seroczyńska; Leszek Kalinowski; Jarosław Skokowski; Edyta Reszka
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

7.  Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility.

Authors:  Clara Benna; Senthilkumar Rajendran; Giovanna Spiro; Chiara Menin; Luigi Dall'Olmo; Carlo Riccardo Rossi; Simone Mocellin
Journal:  J Transl Med       Date:  2021-02-06       Impact factor: 5.531

8.  Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population.

Authors:  Maria Giulia Bacalini; Flavia Palombo; Paolo Garagnani; Cristina Giuliani; Claudio Fiorini; Leonardo Caporali; Michelangelo Stanzani Maserati; Sabina Capellari; Martina Romagnoli; Sara De Fanti; Luisa Benussi; Giuliano Binetti; Roberta Ghidoni; Daniela Galimberti; Elio Scarpini; Marina Arcaro; Enrica Bonanni; Gabriele Siciliano; Michelangelo Maestri; Biancamaria Guarnieri; Morena Martucci; Daniela Monti; Valerio Carelli; Claudio Franceschi; Chiara La Morgia; Aurelia Santoro
Journal:  Geroscience       Date:  2021-12-18       Impact factor: 7.581

Review 9.  Evidences of Polymorphism Associated with Circadian System and Risk of Pathologies: A Review of the Literature.

Authors:  F J Valenzuela; J Vera; C Venegas; S Muñoz; S Oyarce; K Muñoz; C Lagunas
Journal:  Int J Endocrinol       Date:  2016-05-22       Impact factor: 3.257

Review 10.  The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma.

Authors:  Yanan Jiang; Xiuyun Shen; Moyondafoluwa Blessing Fasae; Fengnan Zhi; Lu Chai; Yue Ou; Hai Feng; Siwei Liu; Ying Liu; Shucai Yang
Journal:  Oxid Med Cell Longev       Date:  2021-10-16       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.